CN107970505B - Portable insulin atomization drug delivery device - Google Patents
Portable insulin atomization drug delivery device Download PDFInfo
- Publication number
- CN107970505B CN107970505B CN201610941705.2A CN201610941705A CN107970505B CN 107970505 B CN107970505 B CN 107970505B CN 201610941705 A CN201610941705 A CN 201610941705A CN 107970505 B CN107970505 B CN 107970505B
- Authority
- CN
- China
- Prior art keywords
- medicine
- guide rod
- atomization
- atomizing
- micropore
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0066—Inhalators with dosage or measuring devices with means for varying the dose size
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a portable insulin atomization administration device, which is provided with a blood sugar detection device, a blood sugar analysis circuit, an ultrasonic circuit for controlling administration dosage, a micropore ultrasonic atomization sheet and the like, wherein the blood sugar analysis circuit automatically inputs data after test and analysis of a blood sample test paper of a patient into the ultrasonic circuit for controlling administration dosage, and the ultrasonic circuit for controlling administration dosage automatically sets the atomization administration dosage of insulin. When medicine is sucked, the micropore ultrasonic atomization sheet is electrified to work, liquid medicine is vibrated out from the micropores of the atomization sheets on the micropore ultrasonic atomization sheet, medicine mist particles are sucked into alveolus through the medicine mist suction nozzle and enter blood to take effect, and the purpose of controlling blood sugar is achieved.
Description
Technical Field
The invention relates to an insulin atomization drug delivery device for controlling blood sugar of a human body, in particular to a portable insulin atomization drug delivery device.
Technical Field
At present, the diabetes patient mainly adopts the method of insulin injection for controlling blood sugar, which causes trauma and pain to the patient, and part of the diabetes patient is easy to generate fat hyperplasia by long-term insulin injection.
The prior patent No. CN202459676U.S. A technical scheme of a novel insulin administration device, which comprises a tank body, a partition plate is arranged at the bottom of the tank body, an ultrasonic transducer is arranged on the partition plate, an ultrasonic oscillation circuit is arranged below the partition plate, a micro motor is arranged at the upper bottom of the inner side of the tank body through a bracket, and an impeller, … …, is arranged on the shaft of the micro motor.
The technical scheme has a plurality of problems, 1, the ultrasonic transducer adopted by the invention vibrates and atomizes the liquid medicine on the upper surface of the transducer, the atomized particles of the liquid medicine are 10-5 microns, the medicinal fog particles larger than 5 microns can generate a choking physiological reaction, the atomized particles of the liquid medicine are large and have poor flowing property, the medicinal fog particles collide with each other and are condensed into larger medicinal fog particles, part of the medicinal fog particles fall back into the liquid medicine to influence the atomization effect, the wind power generated by the impeller arranged on the shaft of the micro motor is used, the flowing property of the atomized particles is changed, the atomized particles are not changed, part of the medicinal fog particles enter the upper part of a bronchus to generate the choking physiological reaction, and the choking medicinal fog can not reach the lung. 2. "the micro motor is installed through the support in jar inboard upper bottom, and the epaxial impeller of installing of micro motor", after the use, inconvenient thorough washing has the health potential safety hazard. 3. The ultrasonic transducer used in the technical scheme has high power, needs larger electric energy, has large power supply volume, is suitable for being used in fixed places, and is inconvenient to carry. 4. When the device is powered on to work, the ultrasonic transducer atomizes the liquid medicine, the impeller on the miniature motor shaft blows out the medicine mist, and when the device is exhaled, the medicine mist continues to blow out, so that the respiration is influenced, the liquid medicine is wasted, the atomized medicine dose cannot be accurately controlled, 5, the liquid medicine is filled in one time, the preservation of the liquid medicine is not facilitated, the liquid medicine is wasted, and 6, the original property of the liquid medicine can be damaged by heat generated by the working of the ultrasonic transducer.
The patent of the prior art is granted and issued No. CN 201572400U. in the technical scheme of a novel medical micropore atomization medicine absorber, "the liquid medicine case in install micropore piezoceramics atomization piece, …". The micropore piezoelectric ceramic atomizing sheet generates high-frequency oscillation action under the control of the atomizing control board, so that the liquid medicine connected with the micropore piezoelectric ceramic atomizing sheet is vibrated out through micropores on the micropore piezoelectric ceramic atomizing sheet to form fog which is absorbed by a patient. The bottom surface of the micropore piezoelectric ceramic atomizing sheet is attached to a water absorption cotton core, the water absorption cotton core is connected with the bottom surface of the liquid medicine box, the micropore piezoelectric ceramic atomizing sheet generates a high-frequency oscillation effect under the control of the atomizing control plate, and liquid medicine connected with the water absorption cotton core and the micropore piezoelectric ceramic atomizing sheet is enabled to be vibrated out through micropores of the micropore piezoelectric ceramic atomizing sheet to form fog and then enters the breathing mask through the conduit to be absorbed by a patient. "
The technical scheme has the following problems:
1. the micropore piezoelectric ceramic atomizing sheet is arranged in the liquid medicine tank, most vibration energy of the electrification vibration of the micropore piezoelectric ceramic atomizing sheet is absorbed by liquid medicine in the liquid medicine tank, micropores on the micropore piezoelectric ceramic atomizing sheet vibrate to form a small amount of medicine mist, the quantity of the medicine mist enters the breathing mask through the guide pipe is less, the use requirement of a patient cannot be met, 2, liquid medicine exists below a vibration area of the micropore piezoelectric ceramic atomizing sheet, the liquid medicine below the vibration area cannot vibrate out from the micropores of the micropore piezoelectric ceramic atomizing sheet, the medicine liquid is wasted, 3, the micropore piezoelectric ceramic atomizing sheet is arranged on one side of the lower part of the liquid medicine tank, the liquid medicine in the liquid medicine tank seeps out from the micropores on the micropore piezoelectric ceramic atomizing sheet under the action of pressure, 4, a long bending guide pipe is arranged in the device, the flow resistance of the medicine mist in the bending guide pipe is large, and medicine mist particles mutually collide in, form bigger medicine fog granule, bigger medicine fog granule falls to crooked pipe lower part, influence the quantity that the medicine fog got into respirator, especially the pipe end forms 90 bent angles, the resistance after liquid medicine shakes out from the micropore of micropore piezoceramics atomizing piece is bigger, 5, adopt respirator, part medicine fog can be followed respirator edge and wafted out, extravagant liquid medicine, 6, use the cotton core that absorbs water, though, the energy loss of micropore piezoceramics atomizing piece during operation has been reduced, however, the micropore on micropore piezoceramics atomizing piece can be blockked up to the particle that drops in the cotton core that absorbs water, it is inhaled by the patient after partly particle atomizing shakes out, bring the injury for the patient, the cotton core that absorbs water can't wash, reuse, rotten liquid medicine in the cotton core that absorbs water, cross contamination, bring the sanitary safety hidden danger. 7. The absorbent cotton core can filter partial effective components in the liquid medicine, and the treatment effect is affected. 8. The medicine is inhaled to the face core that uses to absorb water and is supplied with the atomizing liquid medicine of micropore piezoceramics piece vibration, and the absorbent capacity of the cotton core that absorbs water can't satisfy great atomizing volume demand, and the atomizing dose of dosing can't accurate control.
Summary of the invention
In view of the problems in the above-mentioned nebulization drug delivery technical solutions, the present invention provides a portable insulin nebulization drug delivery device to solve the problems in the above-mentioned technical solutions.
The technical scheme of the invention is as follows: a portable insulin aerosolization delivery device comprising: a shell, a medicine bottle, an ultrasonic circuit for controlling the dosage of medicine, a medicine guide rod, a medicine inlet of the medicine guide rod, a sealing gasket, an air flow switch, an air passage, a micropore ultrasonic atomization sheet, a medicine fog suction nozzle, an atomization sheet micropore, an atomization area, a compression ring, an atomization sheet sealing ring, an atomization working chamber, a connecting main body liquid medicine flow passage, a medicine guide rod liquid medicine flow passage, a power supply, a blood sugar detection device, a connecting main body air flow passage, a medicine guide rod air flow passage, an air port electromagnetic valve air inlet, a sealing sleeve, a medicine guide rod air inlet, a liquid crystal display screen and a blood sugar analysis circuit, wherein the connecting main body is arranged in the shell, the connecting main body and the compression ring are fixed on the shell by bolts, the air passage is arranged on the connecting main body, the air flow switch is arranged at, the micropore ultrasonic atomization sheet is arranged between a connecting main body at the lower end of the shell and the press ring, the periphery of the micropore ultrasonic atomization sheet is provided with an atomization sheet sealing ring, the press ring is connected with the connecting main body through a bolt, the micropore ultrasonic atomization sheet and the atomization sheet sealing ring are pressed, fixed and sealed, a plurality of atomization sheet micropores are arranged on the micropore ultrasonic atomization sheet, the atomization working chamber is arranged between the connecting main body and the micropore ultrasonic atomization sheet, in the atomization working chamber, the distance between the inner plane of the micropore ultrasonic atomization sheet and the inner plane of the connecting main body is 0.3-2 mm, the medicine guide rod is arranged on the connecting main body, or the connecting main body and the medicine guide rod are molded into a whole through injection molding, the power supply is fixedly arranged at the bottom in the shell, the blood sugar detection device is fixedly arranged at one side of the bottom in the shell, the liquid crystal display screen is fixedly arranged on the shell, the blood sugar analysis circuit is fixedly arranged inside the shell, the blood sugar detection device is connected with the blood sugar analysis circuit, and the blood sugar analysis circuit is connected with the ultrasonic circuit for controlling the administration dosage.
A micropore ultrasonic atomization piece in portable insulin atomization device on be equipped with a plurality of atomization piece micropore, the micropore diameter of atomization piece is 2 ~ 4 mu m.
A portable insulin atomization device of dosing in control ultrasonic circuit of dose pass through air flow switch and connect the gas port solenoid valve, the ultrasonic circuit of dose is dosed in control passes through air flow switch and connects micropore ultrasonic atomization piece, the air flow switch is closed, the circular telegram of gas port solenoid valve, gas port solenoid valve air inlet is opened, simultaneously, micropore ultrasonic atomization piece work, the air flow switch disconnection, the outage of gas port solenoid valve, gas port solenoid valve air inlet is closed, simultaneously, micropore ultrasonic atomization piece work stops.
In a more preferred embodiment of the present invention, the inlet of the air port solenoid valve in the portable insulin atomizing and administering device is located higher than the air flow passage of the connecting body, and the air port solenoid valve is normally closed.
The medicine guide rod in the portable insulin atomization medicine delivery device is provided with a medicine guide rod liquid medicine flow channel and a medicine guide rod air flow channel, and the cross section of the medicine guide rod liquid medicine flow channel is larger than that of the medicine guide rod air flow channel.
The upper end of a medicine guide rod liquid medicine flow channel in the portable insulin atomization medicine delivery device is provided with a medicine guide rod medicine inlet, the lower end of the medicine guide rod liquid medicine flow channel is communicated with a main body liquid medicine flow channel, the upper end of a medicine guide rod air flow channel is provided with a medicine guide rod air inlet, the lower end of the medicine guide rod air flow channel is communicated with a main body air flow channel, the medicine guide rod medicine inlet is larger than the medicine guide rod air inlet, and the position of the medicine guide rod medicine inlet is lower than that of the medicine guide rod air inlet.
A main connecting body liquid medicine flow passage and a main connecting body air flow passage are arranged on a main connecting body of the portable insulin atomization drug delivery device, the position of the main connecting body liquid medicine flow passage is lower than that of the main connecting body air flow passage, and the cross section of the main connecting body liquid medicine flow passage is larger than that of the main connecting body air flow passage.
A portable insulin atomizes and administers device in micropore ultrasonic atomization piece on be provided with atomizing region, atomizing studio's cross-section is parallel with micropore ultrasonic atomization piece, atomizing studio's cross-sectional shape is the same with the regional shape of atomizing on the micropore ultrasonic atomization piece, atomizing studio's cross-sectional size equals with the regional size of atomizing on the micropore ultrasonic atomization piece, ensures that the liquid medicine in the atomizing studio shakes out, avoids surplus liquid medicine, extravagant liquid medicine.
A medicine fog suction nozzle among portable insulin atomizing device install on the clamping ring, adopt grafting, joint to connect.
Application method
The method 1 comprises the steps of inserting a medicine bottle filled with insulin liquid medicine into a sealing sleeve on a connecting main body, simultaneously puncturing a sealing gasket of the medicine bottle by a medicine guide rod, fixedly sealing the medicine bottle, manually setting the atomized medicine administration dose according to the dose determined by a doctor according to the examination and diagnosis result after starting up, sucking medicine into an oral cavity by a medicine fog suction nozzle, closing an air flow switch under the action of suction force, connecting an ultrasonic circuit for controlling the medicine administration dose to a micropore ultrasonic atomization sheet, enabling the micropore ultrasonic atomization sheet to work, atomizing the liquid medicine, sucking the medicine into alveolus through the medicine fog suction nozzle, disconnecting the air flow switch when breathing is intermittent, stopping atomization of the micropore ultrasonic atomization sheet, enabling the medicine to be sucked for multiple times to reach the set atomized medicine administration dose.
The method 2, after starting up, inserting the blood sample test paper of the diabetic into the blood sugar detection device, inputting the data of the blood sample test paper of the diabetic into the ultrasonic circuit for controlling the dosage, automatically setting the atomization dosage of the insulin by the ultrasonic circuit for controlling the dosage, sucking the medicine by the medicine fog suction nozzle in the oral cavity, closing the airflow switch under the action of suction force, connecting the ultrasonic circuit for controlling the dosage to the micropore ultrasonic atomization sheet, electrifying the micropore ultrasonic atomization sheet to work, atomizing the liquid medicine, sucking the liquid medicine into the alveolus through the medicine fog suction nozzle, disconnecting the airflow switch when breathing is intermittent, stopping the atomization of the micropore ultrasonic atomization sheet, and automatically shutting down the whole machine when the medicine is sucked for multiple times to the set atomization dosage.
Compared with the existing insulin administration technology and the technology of the micropore atomization drug absorber, the invention has the beneficial effects that:
1. a portable insulin atomization administration device combines blood sugar detection and analysis with automatic atomization administration dosage setting, so that a diabetic patient with unstable blood sugar value can detect the blood sugar value before meal, after meal, at regular time and regular period, and automatically analyze and set the atomization administration dosage according to the parameters of the detected blood sugar value.
2. A portable insulin atomizing administration device manually sets an administration dose according to a dose determined by a doctor examining a diagnosis result.
3. A portable insulin atomizing and medicine feeding device adopts a micropore ultrasonic atomizing sheet, liquid medicine atomizing particles are below 5 mu m and are uniform, and the medicine atomizing particles are directly inhaled into alveolus to enter blood without generating a choking physiological reaction.
4. A portable insulin atomization administration device adopts a micropore ultrasonic atomization sheet, has small power, low power consumption, small volume of the whole device, portability and convenient use.
5. The portable insulin atomizing and administrating device has small power of the microporous ultrasonic atomizing sheet and no influence of the heat produced during operation on the property of the liquid medicine.
6. The utility model provides a portable insulin atomizing device of dosing, the distance between the internal planes of micropore ultrasonic atomization piece in the atomizing studio and the internal planes of connecting the main part is 0.3 ~ 2mm, and the thickness of liquid medicine is 0.3 ~ 2mm, and liquid medicine thickness does not influence the atomizing work energy of micropore ultrasonic atomization piece, and micropore ultrasonic atomization piece atomization rate reaches the best.
7. The utility model provides a be provided with the atomizing region on the micropore ultrasonic atomization piece among portable insulin atomization device, the cross-section and the micropore ultrasonic atomization piece of atomizing studio are parallel, the cross-sectional shape of atomizing studio is the same with the regional shape of atomizing on the micropore ultrasonic atomization piece, the cross-sectional size of atomizing studio equals with the regional size of atomizing on the micropore ultrasonic atomization piece, ensure that the liquid medicine in the atomizing studio shakes out, avoid being less than the regional liquid medicine of micropore ultrasonic atomization piece atomizing and can't shake out, surplus liquid medicine, extravagant liquid medicine.
8. The utility model provides a portable insulin atomizing device of dosing, when inhaling the medicine, contains the medicine in the oral cavity with the medicine fog suction nozzle and inhales the medicine, and under the effect of suction force, airflow switch is closed, and micropore ultrasonic atomization piece work, the liquid medicine shakes out, inhales the alveolus through the medicine fog suction nozzle, when breathing intermittence, airflow switch disconnection, micropore ultrasonic atomization piece stop work, and the atomizing stops, accords with respiratory physiological characteristics, when avoiding breathing intermittence, continues the atomizing, extravagant liquid medicine, and it is more convenient to use.
9. When a medicine fog suction nozzle is contained in an oral cavity to suck medicine, the flow speed of medicine fog is accelerated under the action of suction force, and the atomization effect of medicine liquid is improved.
10. The utility model provides a portable insulin atomizing device of dosing, the circular telegram, the gas port solenoid valve is opened, and in the air admission medicine bottle, the liquid medicine flows in and leads the medicine pole and advance the medicine mouth through leading medicine pole liquid medicine runner, connecting main part liquid medicine runner, gets into the atomizing studio, and the outage, the gas port solenoid valve is closed, and in the air stopped to get into the medicine bottle, prevent that the liquid medicine from revealing.
11. A portable insulin atomization administration device adopts a method that a medicine guide rod punctures a medicine bottle sealing gasket, and liquid medicine flows into an atomization working chamber in a closed state, so that pollution is avoided, and sanitation and safety in the use process are ensured.
12. The utility model provides a portable insulin atomizing device of dosing, the medicine fog suction nozzle that adopts is short, and the flow resistance of medicine fog in the medicine fog suction nozzle is little, has avoided the mutual collision of medicine fog particle, has increased the atomization effect of liquid medicine.
The scheme is used for controlling and monitoring the blood sugar of the diabetic.
Drawings
The invention is further illustrated by means of the attached drawings, the examples of which are not to be construed as limiting the invention in any way.
Fig. 1 is a schematic plan view of a portable insulin atomizing administration device with a blood sugar test device installed therein according to the present invention.
Fig. 2 is a schematic plan view of a portable insulin atomizing administration device of the present invention.
Fig. 3 is a schematic view of a microporous ultrasonic atomization sheet in a portable insulin atomization and administration device.
Detailed Description
The invention is further illustrated by reference to the following examples:
example 1
In fig. 1, a schematic plan view of a portable insulin atomizing administration device with a blood sugar test device according to the present invention includes: the device comprises a shell 1, a medicine bottle 2, an ultrasonic circuit 3 for controlling the dosage of the medicine, a medicine guide rod 4, a medicine guide rod medicine inlet 5, a sealing gasket 6, an air flow switch 7, an air passage 8, a micropore ultrasonic atomization sheet 9, a medicine fog suction nozzle 10, an atomization sheet micropore 11, an atomization area 11a, a pressing ring 12, an atomization sheet sealing ring 13, an atomization working chamber 14, a connecting main body 15, a connecting main body medicine liquid flow passage 16, a medicine guide rod medicine liquid flow passage 17, a power supply 18, a blood sugar detection device 19, a connecting main body air flow passage 20, a medicine guide rod air flow passage 21, an air port electromagnetic valve 22, an air port electromagnetic valve air inlet 23, a sealing sleeve 24, a medicine guide rod air inlet 25, a liquid crystal display 26 and a blood sugar analysis circuit 27, wherein the connecting main body 15 is arranged in the shell 1, the connecting main body 15 and the pressing ring 12 are fixed on the shell 1, the position of a connecting main body liquid medicine flow passage 16 is lower than the position of a connecting main body air flow passage 20, the cross section of the connecting main body liquid medicine flow passage 16 is larger than the cross section of the connecting main body air flow passage 20, an air passage 8 is arranged on a connecting main body 15, an air flow switch 7 is arranged at the upper end of the air passage 8 and is fixedly and hermetically connected by clamping, splicing or screw thread, the air passage 8 is communicated with the air flow switch 7, the lower end of the air passage 8 is communicated with the inside of a medicine fog suction nozzle 10, a medicine bottle 2 is arranged in a shell 1, the opening of the medicine bottle 2 is spliced and fixedly and hermetically sealed in a sealing sleeve 24 clamped on the connecting main body 15, an ultrasonic circuit 3 for controlling the administration dosage is arranged in the shell 1 and is fixedly connected by splicing, splicing or bolting, a micropore ultrasonic atomization sheet 9 is arranged, the compression ring 12 is connected with the connecting main body 15 by a bolt, the micropore ultrasonic atomization sheet 9 and the atomization sheet sealing ring 13 are compressed, fixed and sealed, a plurality of atomization sheet micropores 11 are arranged on the micropore ultrasonic atomization sheet 9, the diameter of each atomization sheet micropore 11 is 2-4 mu m, the atomization working chamber 14 is arranged between the connecting main body 15 and the micropore ultrasonic atomization sheet 9, the distance between the inner plane of the micropore ultrasonic atomization sheet 9 and the inner plane of the connecting main body 15 is 0.3-2 mm in the atomization working chamber 14, the medicine guide rod 4 is arranged on the connecting main body 15 and fixedly sealed and connected by splicing and clamping, or the connecting main body 15 and the medicine guide rod 4 are molded into a whole by injection, a medicine guide rod liquid flow passage 17 and a medicine guide rod air flow passage 21 are arranged in the medicine guide rod 4, the cross section of the medicine guide rod liquid flow passage 17 is larger than that of the medicine guide rod air flow passage 21, a medicine guide rod medicine inlet 5 is arranged at the upper end of the medicine guide, the lower end of a medicine guide rod medicine liquid flow passage 17 is communicated with a main body medicine liquid flow passage 16, the upper end of a medicine guide rod air flow passage 21 is provided with a medicine guide rod air inlet 25, the lower end of the medicine guide rod air flow passage 21 is communicated with a main body air flow passage 20, a medicine guide rod medicine inlet 5 is larger than the medicine guide rod air inlet 25, the position of the medicine guide rod medicine inlet 5 is lower than the position of the medicine guide rod air inlet 25, a medicine fog suction nozzle 10 is spliced or clamped on a press ring 12, a power supply 18 is fixedly arranged at the bottom in a shell 1 and fixedly connected by clamping or bolts, a blood sugar detection device 19 is fixedly arranged at one side of the bottom in the shell 1 and fixedly connected by splicing, clamping or bolts, an air port electromagnetic valve 22 is fixedly arranged on a connecting body 15 and communicated with the main body air flow passage 20 and fixedly sealed and connected by splicing, clamping or threads, and the position of an air port air, air port solenoid valve 22 is the normally closed type, liquid crystal display 26 fixed mounting is on casing 1, blood sugar analysis circuit 27 fixed mounting is inside casing 1, adopt grafting, joint or bolt fixed connection, blood sugar detection device 19 connects blood sugar analysis circuit 27, blood sugar analysis circuit 27 connection control doses's ultrasonic circuit 3, control doses's ultrasonic circuit 3 passes through air switch 7 and connects air port solenoid valve 22, control doses's ultrasonic circuit 3 passes through air switch 7 and connects micropore ultrasonic atomization piece 9.
As shown in fig. 1, a medicine bottle 2 containing insulin is inserted into a sealing sleeve 24 on a connecting body 15, the medicine bottle 2 is fixedly sealed, meanwhile, a medicine guide rod 4 pierces a sealing gasket 6 on the medicine bottle 2 to enter the medicine bottle 2, after the medicine bottle is started, blood sample test paper of a diabetic patient is inserted into a blood sugar detection device 19, the blood sugar detection device 19 inputs detection data into a blood sugar analysis circuit 27, the blood sugar analysis circuit 27 inputs the analyzed data into an ultrasonic circuit 3 for controlling the administration dosage, and the ultrasonic circuit 3 for controlling the administration dosage automatically sets the atomization administration time according to the input detection analysis data to determine the administration dosage.
When the medicine atomizing device is used, the medicine atomizing suction nozzle 10 sucks medicine in the oral cavity, under the action of suction force, the airflow switch 7 is closed, the air port electromagnetic valve 22 is powered on and opened, air enters the medicine bottle 2, medicine liquid flows into the medicine inlet 5 through the medicine guide rod, the medicine guide rod liquid medicine flow channel 17 and the connecting main body liquid medicine flow channel 16 to flow into the atomizing working chamber 14, meanwhile, the ultrasonic circuit 3 for controlling the medicine dose is connected with the micropore ultrasonic atomizing sheet 9, the micropore ultrasonic atomizing sheet 9 works, the medicine liquid vibrates out from the micropores 11 of the micropore ultrasonic atomizing sheet 9 and is sucked into alveolus through the medicine atomizing suction nozzle 10, during breathing intermittence, the airflow switch 7 is disconnected, the air port electromagnetic valve 22 is closed, meanwhile, the atomization of the micropore ultrasonic atomizing sheet 9 stops, multiple times of medicine suction reach the set atomized medicine dose.
The cross section of the medicine guide rod 4 is circular, triangular or polygonal, the cross section of the medicine guide rod liquid medicine flow passage 17 and the cross section of the medicine guide rod air flow passage 21 are circular, triangular or polygonal, and the medicine guide rod 4 is made of nontoxic and odorless medical plastic or medical stainless steel.
The connecting body 15, the medicine fog suction nozzle 10 and the press ring 12 are made of nontoxic and tasteless medical plastics.
The atomizing sheet sealing ring 13, the sealing sleeve 24 and the sealing gasket 6 are made of non-toxic and tasteless rubber or plastic.
The electric power of the micropore ultrasonic atomization sheet 9 is 3W, the resonance frequency is 180-100 KHz, and the working voltage is 3-12V.
The power supply 18 is a DC charging power supply or a battery, and the voltage is 3-9V.
Example 2
In fig. 2, a schematic plan view of a portable insulin atomizing administration device of the present invention includes: the device comprises a shell 1, a medicine bottle 2, an ultrasonic circuit 3 for controlling the dosage of the medicine, a medicine guide rod 4, a medicine guide rod medicine inlet 5, a sealing gasket 6, an air flow switch 7, an air passage 8, a micropore ultrasonic atomization sheet 9, a medicine fog suction nozzle 10, an atomization sheet micropore 11, an atomization area 11a, a pressing ring 12, an atomization sheet sealing ring 13, an atomization working chamber 14, a connecting main body 15, a connecting main body medicine liquid flow passage 16, a medicine guide rod medicine liquid flow passage 17, a power supply 18, a medicine bottle cap 19, a connecting main body air flow passage 20, a medicine guide rod air flow passage 21, an air port electromagnetic valve 22, an air port electromagnetic valve air inlet 23, a sealing sleeve 24, a medicine guide rod air inlet 25 and a liquid crystal display screen 26, wherein the connecting main body 15 is arranged in the shell 1, the connecting main body 15 and the pressing ring 12 are fixed on the shell 1 by bolts, the connecting main body medicine liquid flow passage 16 and the connecting main body, the cross section of the connecting body liquid medicine flow passage 16 is larger than that of the connecting body air flow passage 20, an air passage 8 is arranged on the connecting body 15, an air flow switch 7 is installed at the upper end of the air passage 8, clamping connection, insertion connection or thread fixing and sealing connection is adopted, the air passage 8 is communicated with the air flow switch 7, the lower end of the air passage 8 is communicated with the inside of the medicine fog suction nozzle 10, the medicine bottle 2 is arranged inside the shell 1, the bottle opening of the medicine bottle 2 is inserted and connected, the clamping connection is fixedly sealed in a sealing sleeve 24 on the connecting body 15, an ultrasonic circuit 3 for controlling the administration dosage is installed in the shell 1 and is connected by insertion connection, clamping connection or bolt fixing, the micropore ultrasonic atomization sheet 9 is installed between the connecting body 15 and the pressure ring 12 at the lower end of the shell 1, the atomization sheet sealing ring 13 is installed, An atomizing sheet sealing ring 13 is pressed, fixed and sealed, a plurality of atomizing sheet micropores 11 are arranged on a micropore ultrasonic atomizing sheet 9, the diameter of each atomizing sheet micropore 11 is 2-4 microns, an atomizing working chamber 14 is arranged between a connecting main body 15 and the micropore ultrasonic atomizing sheet 9, the distance between the inner plane of the micropore ultrasonic atomizing sheet 9 and the inner plane of the connecting main body 15 is 0.3-2 mm in the atomizing working chamber 14, a medicine guide rod 4 is arranged on the connecting main body 15 and is fixedly and hermetically connected by splicing and clamping, or the connecting main body 15 and the medicine guide rod 4 are molded into a whole by injection, a medicine guide rod liquid medicine flow passage 17 and a medicine guide rod air flow passage 21 are arranged in the medicine guide rod 4, the cross section of the medicine guide rod liquid medicine flow passage 17 is larger than that of the medicine guide rod air flow passage 21, the upper end of the medicine guide rod liquid medicine flow passage 17 is provided with a medicine guide rod medicine inlet 5, the lower end of the medicine guide rod liquid flow passage 17 is communicated, the upper end of the medicine guide rod air flow channel 21 is provided with a medicine guide rod air inlet 25, the lower end of the medicine guide rod air flow channel 21 is communicated and connected with a main body air flow channel 20, a medicine guide rod medicine inlet 5 is larger than the medicine guide rod air inlet 25, the position of the medicine guide rod medicine inlet 5 is lower than the position of the medicine guide rod air inlet 25, a medicine fog suction nozzle 10 is spliced or clamped on a pressing ring 12, a power supply 18 is fixedly arranged at the bottom in a shell 1 and fixedly connected by adopting a clamping or a bolt, an air port electromagnetic valve 22 is fixedly arranged on a connecting body 15 and is communicated and connected with the main body air flow channel 20 and fixedly sealed and connected by adopting splicing, clamping or a thread, the position of an air port electromagnetic valve air inlet 23 is higher than the position of the main body air flow channel 20, the air port electromagnetic valve 22 is of a normally closed type, a liquid crystal display screen 26 is fixedly arranged on the shell, the ultrasonic circuit 3 for controlling the dosage is connected with the micropore ultrasonic atomization sheet 9 through the airflow switch 7.
As shown in fig. 2, the medicine bottle 2 containing insulin is inserted into the sealing sleeve 24 of the connecting body 15, the medicine bottle 2 is fixedly sealed, meanwhile, the medicine guide rod 4 pierces the sealing gasket 6 on the medicine bottle 2 to enter the medicine bottle 2, after starting, the medicine is dosed according to the dose determined by the examination and diagnosis result of the doctor, and the dosing time is manually set to determine the dosing dose.
When the medicine atomizing device is used, the medicine atomizing suction nozzle 10 sucks medicine in the oral cavity, under the action of suction force, the airflow switch 7 is closed, the air port electromagnetic valve 22 is powered on and opened, air enters the medicine bottle 2, medicine liquid flows into the medicine inlet 5 through the medicine guide rod, the medicine guide rod liquid medicine flow channel 17 and the connecting main body liquid medicine flow channel 16 to flow into the atomizing working chamber 14, meanwhile, the ultrasonic circuit 3 for controlling the medicine dose is connected with the micropore ultrasonic atomizing sheet 9, the micropore ultrasonic atomizing sheet 9 works, the medicine liquid vibrates out from the micropores 11 of the micropore ultrasonic atomizing sheet 9 and is sucked into alveolus through the medicine atomizing suction nozzle 10, during breathing intermittence, the airflow switch 7 is disconnected, the air port electromagnetic valve 22 is closed, meanwhile, the atomization of the micropore ultrasonic atomizing sheet 9 stops, multiple times of medicine suction reach the set atomized medicine dose.
The cross section of the medicine guide rod 4 is circular, triangular or polygonal, the cross section of the medicine guide rod liquid medicine flow passage 17 and the cross section of the medicine guide rod air flow passage 21 are circular, triangular or polygonal, and the medicine guide rod 4 is made of nontoxic and odorless medical plastic or medical stainless steel.
The connecting body 15, the medicine fog suction nozzle 10 and the press ring 12 are made of nontoxic and tasteless medical plastics.
The atomizing sheet sealing ring 13, the sealing sleeve 24 and the sealing gasket 6 are made of non-toxic and tasteless rubber or plastic.
The electric power of the micropore ultrasonic atomization sheet 9 is 3W, the resonance frequency is 180-100 KHz, and the working voltage is 3-12V.
The power supply 18 is a DC charging power supply or a battery, and the voltage is 3-9V.
In the schematic diagram of the microporous ultrasonic atomization sheet in the portable insulin atomization and administration device shown in fig. 3, the microporous ultrasonic atomization sheet 9 is provided with an atomization area 11 a.
As shown in fig. 1, 2 and 3, the cross section of the atomizing operating chamber 14 is parallel to the microporous ultrasonic atomizing sheet 9, the cross section of the atomizing operating chamber 14 has the same shape as the atomizing area 11a on the microporous ultrasonic atomizing sheet 9, and the cross section of the atomizing operating chamber 14 has the same size as the atomizing area 11a on the microporous ultrasonic atomizing sheet 9, so that the liquid medicine in the atomizing operating chamber 14 is ensured to be vibrated out, and the liquid medicine is prevented from being remained and wasted.
Claims (6)
1. A portable insulin aerosolization delivery device comprising: a shell (1), a medicine bottle (2), an ultrasonic circuit (3) for controlling the dosage of medicine, a medicine guide rod (4), a medicine guide rod medicine inlet (5), a sealing gasket (6), an air flow switch (7), an air passage (8), a micropore ultrasonic atomization sheet (9), a medicine fog suction nozzle (10), an atomization sheet micropore (11), an atomization area (11a), a pressing ring (12), an atomization sheet sealing ring (13), an atomization working chamber (14), a connecting body (15), a connecting body liquid medicine flow passage (16), a medicine guide rod liquid medicine flow passage (17), a power supply (18), a blood sugar detection device (19), a connecting body air flow passage (20), a medicine guide rod air flow passage (21), an air port electromagnetic valve (22), an air port electromagnetic valve air inlet (23), a sealing sleeve (24), a medicine guide rod air inlet (25), a liquid crystal display screen (26) and a blood sugar analysis circuit (27), wherein the connecting body (15) is arranged in, the connecting main body (15) and the pressing ring (12) are fixed on the shell (1) through bolts, an air passage (8) is arranged on the connecting main body (15), an air flow switch (7) is installed at the upper end of the air passage (8), the air passage (8) is communicated with the air flow switch (7), the lower end of the air passage (8) is communicated with the inside of a medicine fog suction nozzle (10), an ultrasonic circuit (3) for controlling the medicine dosage is installed in the shell (1), a micropore ultrasonic atomization sheet (9) is installed between the connecting main body (15) at the lower end of the shell (1) and the pressing ring (12), an atomization sheet sealing ring (13) is installed at the circumferential edge of the micropore ultrasonic atomization sheet (9), the pressing ring (12) is connected with the connecting main body (15) through bolts, the micropore ultrasonic atomization sheet (9) and the atomization sheet sealing ring (13) are pressed, fixed and sealed, and a, the atomizing working chamber (14) is arranged between the connecting main body (15) and the micropore ultrasonic atomizing sheet (9), in the atomizing working chamber (14), the distance between the inner plane of the micropore ultrasonic atomizing sheet (9) and the inner plane of the connecting main body (15) is 0.3-2 mm, the thickness of the liquid medicine does not influence the atomizing working energy of the micropore ultrasonic liquid atomizing sheet (9), the atomizing rate of the micropore ultrasonic liquid atomizing sheet (9) is optimal, the medicine guide rod (4) is arranged on the connecting main body (15), or the connecting main body (15) and the medicine guide rod (4) are molded into a whole by injection, the power supply (18) is fixedly arranged at the bottom in the shell (1), the blood sugar detection device (19) is fixedly arranged at one side of the bottom in the shell (1), the electromagnetic valve (22) is fixedly arranged on the connecting main body (15), and is communicated with the connecting main body air flow passage (20), the liquid crystal display screen (26) is fixedly arranged on the shell (1), the blood sugar analysis circuit (27) is fixedly arranged in the shell (1), the blood sugar detection device (19) is connected with the blood sugar analysis circuit (27), and the blood sugar analysis circuit (27) is connected with the ultrasonic circuit (3) for controlling the administration dosage; the ultrasonic circuit (3) for controlling the administration dosage is connected with the air port electromagnetic valve (22) through the air flow switch (7), and the ultrasonic circuit (3) for controlling the administration dosage is connected with the micropore ultrasonic atomization sheet (9) through the air flow switch (7).
2. A portable insulin atomizing delivery device as set forth in claim 1: the method is characterized in that: the position of the air inlet (23) of the air port electromagnetic valve is higher than that of the air channel (20) of the connecting main body, and the air port electromagnetic valve (22) is of a normally closed type.
3. A portable insulin atomizing delivery device as set forth in claim 1: the method is characterized in that: a drug guide rod liquid medicine flow passage (17) and a drug guide rod air flow passage (21) are arranged in the drug guide rod (4), and the cross section of the drug guide rod liquid medicine flow passage (17) is larger than that of the drug guide rod air flow passage (21).
4. A portable insulin atomizing delivery device as set forth in claim 1: the method is characterized in that: the upper end of the medicine guide rod liquid medicine flow channel (17) is provided with a medicine guide rod medicine inlet (5), the lower end of the medicine guide rod liquid medicine flow channel (17) is communicated with the main body liquid medicine flow channel (16), the upper end of the medicine guide rod air flow channel (21) is provided with a medicine guide rod air inlet (25), the lower end of the medicine guide rod air flow channel (21) is communicated with the main body air flow channel (20), the medicine guide rod medicine inlet (5) is larger than the medicine guide rod air inlet (25), and the position of the medicine guide rod medicine inlet (5) is lower than that of the medicine guide rod air inlet (25).
5. A portable insulin atomizing delivery device as set forth in claim 1: the method is characterized in that: the connecting body (15) is provided with a connecting body liquid medicine flow passage (16) and a connecting body air flow passage (20), the position of the connecting body liquid medicine flow passage (16) is lower than that of the connecting body air flow passage (20), and the cross section of the connecting body liquid medicine flow passage (16) is larger than that of the connecting body air flow passage (20).
6. A portable insulin atomizing delivery device as set forth in claim 1: the method is characterized in that: an atomization area (11a) is arranged on the micropore ultrasonic atomization sheet (9), the cross section of the atomization working chamber (14) is parallel to the micropore ultrasonic atomization sheet (9), the cross section of the atomization working chamber (14) is the same as the shape of the atomization area (11a) on the micropore ultrasonic atomization sheet (9), and the cross section of the atomization working chamber (14) is equal to the size of the atomization area (11a) on the micropore ultrasonic atomization sheet (9).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610941705.2A CN107970505B (en) | 2016-10-24 | 2016-10-24 | Portable insulin atomization drug delivery device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610941705.2A CN107970505B (en) | 2016-10-24 | 2016-10-24 | Portable insulin atomization drug delivery device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107970505A CN107970505A (en) | 2018-05-01 |
| CN107970505B true CN107970505B (en) | 2020-11-03 |
Family
ID=62004071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610941705.2A Active CN107970505B (en) | 2016-10-24 | 2016-10-24 | Portable insulin atomization drug delivery device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107970505B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620970A (en) * | 2016-10-30 | 2017-05-10 | 田中枢 | Portable atomization and administration device |
| CN111956917B (en) * | 2020-08-18 | 2022-04-01 | 深圳市贝格美科技有限公司 | Multifunctional ultrasonic atomizer |
| CN114642795B (en) * | 2020-12-18 | 2024-02-27 | 深圳麦克韦尔科技有限公司 | Electronic atomizing device |
| CN113008590B (en) * | 2021-03-10 | 2023-11-24 | 方文龙 | Atomization detection equipment for atomization sheet and detection method thereof |
| CN113304361B (en) * | 2021-06-07 | 2022-10-14 | 田中枢 | Accurate insulin atomization drug delivery and respiratory system atomization drug delivery device |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082436A9 (en) * | 2004-02-26 | 2006-11-16 | Dexcom Inc | Integrated delivery device for continuous glucose sensor |
| CN1960777A (en) * | 2004-04-02 | 2007-05-09 | 美国政府健康及人类服务部，疾病控制和预防中心 | Aerosol delivery systems and methods |
| CN101461969A (en) * | 2007-12-21 | 2009-06-24 | 霍夫曼-拉罗奇有限公司 | Blood glucose system with time synchronisation |
| US20110011399A1 (en) * | 1998-04-30 | 2011-01-20 | Abbott Diabetes Care Inc. | Analyte Monitoring Device and Methods of Use |
| US20120227737A1 (en) * | 2006-12-06 | 2012-09-13 | Medtronic Minimed, Inc. | Analyte sensor and method of using the same |
| CN203943992U (en) * | 2014-06-25 | 2014-11-19 | 杭州市中医院 | Medical administration and atomization device |
| CN105396206A (en) * | 2015-11-27 | 2016-03-16 | 江苏鹿得医疗电子股份有限公司 | Intermittent air supply type medical ultrasonic nebulizer with inspiration induction |
| WO2016090291A1 (en) * | 2014-12-05 | 2016-06-09 | Dance Biopharm, Inc. | Integration of glucose data to adjust inhaled insulin dose |
| CN105706096A (en) * | 2013-10-25 | 2016-06-22 | 阿瑞斯贸易股份公司 | Patient care system reporting adherence to treatment regimen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201808138T4 (en) * | 2013-08-16 | 2018-07-23 | Vectura Gmbh | Dosing system for an inhalation device. |
| CN205055096U (en) * | 2015-10-18 | 2016-03-02 | 王运华 | Otolaryngology medical vaporizer |
-
2016
- 2016-10-24 CN CN201610941705.2A patent/CN107970505B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110011399A1 (en) * | 1998-04-30 | 2011-01-20 | Abbott Diabetes Care Inc. | Analyte Monitoring Device and Methods of Use |
| WO2005082436A9 (en) * | 2004-02-26 | 2006-11-16 | Dexcom Inc | Integrated delivery device for continuous glucose sensor |
| CN1960777A (en) * | 2004-04-02 | 2007-05-09 | 美国政府健康及人类服务部，疾病控制和预防中心 | Aerosol delivery systems and methods |
| US20120227737A1 (en) * | 2006-12-06 | 2012-09-13 | Medtronic Minimed, Inc. | Analyte sensor and method of using the same |
| CN101461969A (en) * | 2007-12-21 | 2009-06-24 | 霍夫曼-拉罗奇有限公司 | Blood glucose system with time synchronisation |
| CN105706096A (en) * | 2013-10-25 | 2016-06-22 | 阿瑞斯贸易股份公司 | Patient care system reporting adherence to treatment regimen |
| CN203943992U (en) * | 2014-06-25 | 2014-11-19 | 杭州市中医院 | Medical administration and atomization device |
| WO2016090291A1 (en) * | 2014-12-05 | 2016-06-09 | Dance Biopharm, Inc. | Integration of glucose data to adjust inhaled insulin dose |
| CN105396206A (en) * | 2015-11-27 | 2016-03-16 | 江苏鹿得医疗电子股份有限公司 | Intermittent air supply type medical ultrasonic nebulizer with inspiration induction |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107970505A (en) | 2018-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107970505B (en) | Portable insulin atomization drug delivery device | |
| CN106620970A (en) | Portable atomization and administration device | |
| JP2012503518A (en) | Auxiliary oxygen delivery device | |
| US20130255678A1 (en) | Nebulizer for infants and respiratory compromised patients | |
| WO2009111612A1 (en) | Aerosolization device | |
| CN210750705U (en) | Portable small-size atomizer | |
| CN113304361B (en) | Accurate insulin atomization drug delivery and respiratory system atomization drug delivery device | |
| CN106823079A (en) | A kind of quantitative atomized medicine introducing device of delivery type | |
| WO1997004826A1 (en) | Powdery medicine dosing device | |
| WO2018107587A1 (en) | New atomization drug delivery apparatus convenient for atomization treatment of perioperative patient | |
| CN209864910U (en) | Medicine feeding device for pediatric nursing | |
| CN106039495B (en) | Intelligent inhaler | |
| CN114470442A (en) | Pen-shaped drug delivery device for aerosol inhalation | |
| CN111420188A (en) | High-efficient vibration atomizer | |
| CN212593378U (en) | High-performance vibrating micro-mesh atomizer | |
| CN203507247U (en) | Nebulizer special for mechanical ventilation | |
| CN219148837U (en) | Instant atomizing and instant inhalation type atomizing drug delivery device | |
| CN201543064U (en) | Ultrasonic atomizing device | |
| CN218356880U (en) | Atomizing medicine feeder | |
| CN201064600Y (en) | Respiratory tract drug administration electronic atomizer | |
| CN107126604A (en) | A kind of medical mask | |
| AU2021101022A4 (en) | Portable insulin atomization administration device | |
| CN217525994U (en) | Quantization type atomizer for children | |
| CN105477752A (en) | Atomizer capable of detecting breathing state | |
| CN212416581U (en) | Combined portable inhalation device containing disposable special bottle for atomized medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |